Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States.
Pacira Biosciences stock last closed at $47.23, down 2.11% from the previous day, and has decreased 11.37% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.27 percentage points. Pacira Biosciences stock is currently +2.61% from its 52-week low of $46.03, and -42.51% from its 52-week high of $82.16.
There are currently 45.88M PCRX shares outstanding. The market capitalization of PCRX is $2.17B. In the past 24 hours, 508,413 PCRX shares were traded.
You need an online brokerage account to access the NASDAQ market and buy PCRX stock.
We believe that eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now.Open eToro Account
Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PCRX stock today.
Watch the video below to see the process of transferring funds into your new brokerage account.
It's very important to evaluate stocks before you buy, so you actually wrap your head around the risk and upside.
WallStreetZen was created to help average investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on PCRX's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge PCRX's intrinsic value.
Using relative valuations methods:
You can access more valuation analysis on PCRX's stock here.
Out of 6 Equities analysts who research PCRX, the consensus analyst rating on PCRX is a Buy
Gary Nachman, a bottom 13% analyst from BMO Capital maintains PCRX with a hold rating and lowers their PCRX price target from $66.00 to $60.00, on Nov 7, 2022.
Oren Livnat, a bottom 4% analyst from HC Wainwright & Co. maintains PCRX with a buy rating and lowers their PCRX price target from $83.00 to $76.00, on Nov 4, 2022.
Serge Belanger, a bottom 30% analyst from Needham maintains PCRX with a buy rating and lowers their PCRX price target from $76.00 to $74.00, on Nov 3, 2022.
Glen Santangelo, a top 30% analyst from Jefferies assumes PCRX with a strong buy rating and announces their PCRX price target of $66.00, on Oct 21, 2022.
David Amsellem, a top 11% analyst from Piper Sandler maintains PCRX with a strong buy rating and lowers their PCRX price target from $84.00 to $80.00, on Jul 21, 2022.
You can dig deeper into what analysts are projecting on the Pacira Biosciences stock forecast page.
Last year, PCRX earnings were $20.88M. In the past three year, PCRX's earnings have grown by 200% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.81%.
Last year, PCRX revenue was $654.06M. Over the past 5 year, PCRX's revenue has increased by 18.45% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 44.46%.
Dig into PCRX's earnings and revenue performance here.
In the past year, executives and large shareholders at PCRX have bought more shares than they have sold.
Max Reinhardt, President Rest of World of PCRX, was the latest PCRX insider to sell. They sold $80,040.00 worth of PCRX shares on Oct 7, 2022.
Research more about who owns PCRX shares here.
No, Pacira Biosciences doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two primary options:
Click the Open Trade button and your broker will execute your order.
If you want additional info about buying stocks on eToro, click the how to video below:
Now that you own some PCRX shares, you'll want to stay up-to-date on your new company.
Create a watchlist to track the most important metrics related to your PCRX stock.
To reiterate, here are the 6 steps you need to take to buy Pacira Biosciences stock right now:
If you are looking for a brokerage, eToro is our favorite venue.Get Started with eToro Today
If you would like to get the latest scoop on your investment in Pacira Biosciences, create your watchlist below.
How much does it cost to buy one Pacira Biosciences share?
Is now a good time to buy Pacira Biosciences stock?
What is the best way to buy Pacira Biosciences stock?